Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
MRVI Maravai Lifesciences Holdings Inc
- Stocks
- Healthcare
- NASDAQ: MRVI
Price (delayed)
$1.98
Market cap
$503.59M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.05
Enterprise value
$509.02M
Maravai LifeSciences enables the development of drug therapies, diagnostics and novel vaccines and supports research on human diseases through its portfolio of market-leading companies and proprietary technologies. Maravai companies are
Highlights
The company's debt fell by 41% YoY and by 41% QoQ
MRVI's net income is up by 36% since the previous quarter but it is down by 22% year-on-year
Maravai Lifesciences Holdings's EPS has increased by 36% from the previous quarter but it has decreased by 17% YoY
Maravai Lifesciences Holdings's quick ratio has decreased by 34% QoQ and by 12% YoY
Maravai Lifesciences Holdings's gross profit has decreased by 23% YoY and by 16% QoQ
Key stats
What are the main financial stats of MRVI
Market
Valuations
Earnings
Shares outstanding
254.34M
Market cap
$503.59M
Enterprise value
$509.02M
Price to earnings (P/E)
N/A
Price to book (P/B)
1.54
Price to sales (P/S)
1.05
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.96
Revenue
$259.19M
Gross profit
$108.31M
Operating income
-$237.62M
Net income
-$144.85M
EBIT
-$99.01M
EBITDA
-$42.14M
Free cash flow
-$15.05M
Per share
Balance sheet
Liquidity
EPS
-$1.05
EPS diluted
-$1.05
Free cash flow per share
-$0.11
Book value per share
$1.29
Revenue per share
$1.88
TBVPS
$4.74
Total assets
$1.01B
Total liabilities
$431.04M
Debt
$327.83M
Equity
$325.29M
Working capital
$372.18M
Debt to equity
1.01
Current ratio
7.53
Quick ratio
6.34
Net debt/EBITDA
-0.13
Margins
Efficiency
Dividend
EBITDA margin
-16.3%
Gross margin
41.8%
Net margin
-55.9%
Operating margin
-91.7%
Return on assets
-11.2%
Return on equity
-38.2%
Return on invested capital
-12.8%
Return on capital employed
-10.4%
Return on sales
-38.2%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
MRVI stock price
How has the Maravai Lifesciences Holdings stock price performed over time
Intraday
-4.35%
1 week
-4.35%
1 month
2.06%
1 year
-79.92%
YTD
-63.67%
QTD
-10.41%
Financial performance
How have Maravai Lifesciences Holdings's revenue and profit performed over time
Revenue
$259.19M
Gross profit
$108.31M
Operating income
-$237.62M
Net income
-$144.85M
Gross margin
41.8%
Net margin
-55.9%
MRVI's net income is up by 36% since the previous quarter but it is down by 22% year-on-year
The company's net margin fell by 36% YoY but it rose by 31% QoQ
Maravai Lifesciences Holdings's gross profit has decreased by 23% YoY and by 16% QoQ
The operating margin has decreased by 21% from the previous quarter
Price vs fundamentals
How does MRVI's price correlate with its fundamentals
Growth
What is Maravai Lifesciences Holdings's growth rate over time
Valuation
What is Maravai Lifesciences Holdings stock price valuation
P/E
N/A
P/B
1.54
P/S
1.05
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.96
Maravai Lifesciences Holdings's EPS has increased by 36% from the previous quarter but it has decreased by 17% YoY
MRVI's price to book (P/B) is 93% less than its 5-year quarterly average of 23.2 and 69% less than its last 4 quarters average of 4.9
The company's equity fell by 22% YoY and by 6% QoQ
The price to sales (P/S) is 76% less than the 5-year quarterly average of 4.4 and 72% less than the last 4 quarters average of 3.7
Maravai Lifesciences Holdings's revenue has decreased by 10% YoY and by 6% from the previous quarter
Efficiency
How efficient is Maravai Lifesciences Holdings business performance
The company's return on invested capital has shrunk by 126% YoY and by 118% QoQ
Maravai Lifesciences Holdings's ROS has plunged by 118% from the previous quarter and by 116% YoY
The return on assets has dropped by 96% year-on-year but it has grown by 30% since the previous quarter
The return on equity has dropped by 59% year-on-year but it is up by 32% since the previous quarter
Dividends
What is MRVI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for MRVI.
Financial health
How did Maravai Lifesciences Holdings financials performed over time
MRVI's total assets is 134% greater than its total liabilities
The total liabilities has decreased by 38% YoY and by 35% from the previous quarter
Maravai Lifesciences Holdings's quick ratio has decreased by 34% QoQ and by 12% YoY
The company's debt fell by 41% YoY and by 41% QoQ
Maravai Lifesciences Holdings's debt to equity has decreased by 37% QoQ and by 25% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.